Skip to main content

Clinical Assessment Study in Crigler-Najjar Syndrome

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Clinical Assessment Study in Crigler-Najjar Syndrome

Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)

Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis

Comparing Five Oral Analgesics for Treatment of Acute Pain in the Emergency Department (ED)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Comparing Five Oral Analgesics for Treatment of Acute Pain in the Emergency Department (ED)

Developmental Impact of NICU Exposures (DINE)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Developmental Impact of NICU Exposures (DINE)

Metoclopramide for Post-Traumatic Headache. A Pilot Study

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Metoclopramide for Post-Traumatic Headache. A Pilot Study

Electronic Defaults to Reduce Opioid Prescribing in Dentistry Practices

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Electronic Defaults to Reduce Opioid Prescribing in Dentistry Practices

Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer

Deceased Donor Biomarkers and Recipient Outcomes

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Deceased Donor Biomarkers and Recipient Outcomes

Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 108
  • Page 109
  • Page 110
  • Page 111
  • Page 112
  • Page 113
  • Page 114
  • Page 115
  • Page 116
  • …
  • Next page Next
  • Last page Last
Subscribe to